Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dr. Guerriero has a PhD in Molecular and Cellular Biology and Immunology and Pathology from Stony Brook University where she trained under Dr. Wei-Xing Zong and completed her thesis entitled, “A study of cell death pathways and innate immunity in cancer chemotherapy”. Dr. Guerriero completed her postdoctoral training in the laboratory of Dr. Anthony Letai at Dana-Farber Cancer Institute where she investigated the role of tumor macrophages in breast cancer and identified novel mechanisms to target pro-tumor macrophages to an anti-tumor phenotype to induce tumor regression. Dr. Guerriero transitioned to a faculty position as an Instructor in Medicine at Harvard Medical School and joined Dr. Elizabeth Mittendorf's laboratory as the Director of the Breast Tumor Immunology Laboratory in the Susan F. Smith Women’s Cancer Program at Dana-Farber Cancer Institute. In October 2020, Dr. Guerriero launched her independent laboratory at Brigham and Women's Hospital and continues to serve as the Director of the Breast Tumor Immunology Laboratory.
Dana-Farber Cancer Institute (BTIL)450 Brookline AveSmith 928Boston, MA 02215Get Directions
Brigham and Women’s Hospital (Guerriero Lab)20 Shattuck StreetThorn 407Boston, MA 02115Get Directions